Could miRNA Signatures be Useful for Predicting Uterine Sarcoma and Carcinosarcoma Prognosis and Treatment?

Changes in microRNA (miRNA) expression may lead to cancer development and/or contribute to its progression; however, their role in uterine sarcomas is poorly understood. Uterine sarcomas (US) belong to a rare class of heterogeneous tumors, representing about 1% of all gynecologic neoplasms. This stu...

Full description

Bibliographic Details
Main Authors: Laura Gonzalez dos Anjos, Bruna Cristine de Almeida, Thais Gomes de Almeida, André Mourão Lavorato Rocha, Giovana De Nardo Maffazioli, Fernando Augusto Soares, Isabela Werneck da Cunha, Edmund Chada Baracat, Katia Candido Carvalho
Format: Article
Language:English
Published: MDPI AG 2018-09-01
Series:Cancers
Subjects:
Online Access:http://www.mdpi.com/2072-6694/10/9/315
_version_ 1797708987795243008
author Laura Gonzalez dos Anjos
Bruna Cristine de Almeida
Thais Gomes de Almeida
André Mourão Lavorato Rocha
Giovana De Nardo Maffazioli
Fernando Augusto Soares
Isabela Werneck da Cunha
Edmund Chada Baracat
Katia Candido Carvalho
author_facet Laura Gonzalez dos Anjos
Bruna Cristine de Almeida
Thais Gomes de Almeida
André Mourão Lavorato Rocha
Giovana De Nardo Maffazioli
Fernando Augusto Soares
Isabela Werneck da Cunha
Edmund Chada Baracat
Katia Candido Carvalho
author_sort Laura Gonzalez dos Anjos
collection DOAJ
description Changes in microRNA (miRNA) expression may lead to cancer development and/or contribute to its progression; however, their role in uterine sarcomas is poorly understood. Uterine sarcomas (US) belong to a rare class of heterogeneous tumors, representing about 1% of all gynecologic neoplasms. This study aimed to assess the expression profile of 84 cancer-related miRNAs and to evaluate their correlation with clinical pathological features. Eighty-two formalin-fixed paraffin-embedded (FFPE) samples were selected. In leiomyosarcoma (LMS), there was an association of lower cancer-specific survival (CSS) with the downregulation of miR-125a-5p and miR-10a-5p, and the upregulation of miR-196a-5p and miR-34c-5p. In carcinosarcoma (CS), lower CSS was associated with the upregulation of miR-184, and the downregulation of let-7b-5p and miR-124. In endometrial stromal sarcomas (ESS), the upregulation of miR-373-3p, miR-372-3p, and let-7b-5p, and the down-expression of let-7f-5p, miR-23-3p, and let-7b-5p were associated with lower CSS. Only miR-138-5p upregulation was associated with higher survival rates. miR-335-5p, miR-301a-3p, and miR-210-3p were more highly expressed in patients with tumor metastasis and relapse. miR-138-5p, miR-146b-5p, and miR-218-5p expression were associated with higher disease-free survival (DFS) in treated patients. These miRNAs represent potential prediction markers for prognosis and treatment response in these tumors.
first_indexed 2024-03-12T06:29:42Z
format Article
id doaj.art-25703b197e864633a71bd79f7d0ae171
institution Directory Open Access Journal
issn 2072-6694
language English
last_indexed 2024-03-12T06:29:42Z
publishDate 2018-09-01
publisher MDPI AG
record_format Article
series Cancers
spelling doaj.art-25703b197e864633a71bd79f7d0ae1712023-09-03T01:40:22ZengMDPI AGCancers2072-66942018-09-0110931510.3390/cancers10090315cancers10090315Could miRNA Signatures be Useful for Predicting Uterine Sarcoma and Carcinosarcoma Prognosis and Treatment?Laura Gonzalez dos Anjos0Bruna Cristine de Almeida1Thais Gomes de Almeida2André Mourão Lavorato Rocha3Giovana De Nardo Maffazioli4Fernando Augusto Soares5Isabela Werneck da Cunha6Edmund Chada Baracat7Katia Candido Carvalho8Laboratório de Ginecologia Estrutural e Molecular (LIM 58), Disciplina de Ginecologia, Departamento de Obstetricia e Ginecologia, Hospital das Clinicas da Faculdade de Medicina da Universidade de Sao Paulo, HCFMUSP, SP, BR Av. Dr Arnaldo 455, sala 4121, Cerqueira Cesar, São Paulo 05403-010, BrazilLaboratório de Ginecologia Estrutural e Molecular (LIM 58), Disciplina de Ginecologia, Departamento de Obstetricia e Ginecologia, Hospital das Clinicas da Faculdade de Medicina da Universidade de Sao Paulo, HCFMUSP, SP, BR Av. Dr Arnaldo 455, sala 4121, Cerqueira Cesar, São Paulo 05403-010, BrazilLaboratório de Ginecologia Estrutural e Molecular (LIM 58), Disciplina de Ginecologia, Departamento de Obstetricia e Ginecologia, Hospital das Clinicas da Faculdade de Medicina da Universidade de Sao Paulo, HCFMUSP, SP, BR Av. Dr Arnaldo 455, sala 4121, Cerqueira Cesar, São Paulo 05403-010, BrazilHospital A C Camargo Cancer Center, SP, BR R. Tamandaré, 753 Liberdade, São Paulo 05403-010, BrazilLaboratório de Ginecologia Estrutural e Molecular (LIM 58), Disciplina de Ginecologia, Departamento de Obstetricia e Ginecologia, Hospital das Clinicas da Faculdade de Medicina da Universidade de Sao Paulo, HCFMUSP, SP, BR Av. Dr Arnaldo 455, sala 4121, Cerqueira Cesar, São Paulo 05403-010, BrazilHospital A C Camargo Cancer Center, SP, BR R. Tamandaré, 753 Liberdade, São Paulo 05403-010, BrazilHospital A C Camargo Cancer Center, SP, BR R. Tamandaré, 753 Liberdade, São Paulo 05403-010, BrazilLaboratório de Ginecologia Estrutural e Molecular (LIM 58), Disciplina de Ginecologia, Departamento de Obstetricia e Ginecologia, Hospital das Clinicas da Faculdade de Medicina da Universidade de Sao Paulo, HCFMUSP, SP, BR Av. Dr Arnaldo 455, sala 4121, Cerqueira Cesar, São Paulo 05403-010, BrazilLaboratório de Ginecologia Estrutural e Molecular (LIM 58), Disciplina de Ginecologia, Departamento de Obstetricia e Ginecologia, Hospital das Clinicas da Faculdade de Medicina da Universidade de Sao Paulo, HCFMUSP, SP, BR Av. Dr Arnaldo 455, sala 4121, Cerqueira Cesar, São Paulo 05403-010, BrazilChanges in microRNA (miRNA) expression may lead to cancer development and/or contribute to its progression; however, their role in uterine sarcomas is poorly understood. Uterine sarcomas (US) belong to a rare class of heterogeneous tumors, representing about 1% of all gynecologic neoplasms. This study aimed to assess the expression profile of 84 cancer-related miRNAs and to evaluate their correlation with clinical pathological features. Eighty-two formalin-fixed paraffin-embedded (FFPE) samples were selected. In leiomyosarcoma (LMS), there was an association of lower cancer-specific survival (CSS) with the downregulation of miR-125a-5p and miR-10a-5p, and the upregulation of miR-196a-5p and miR-34c-5p. In carcinosarcoma (CS), lower CSS was associated with the upregulation of miR-184, and the downregulation of let-7b-5p and miR-124. In endometrial stromal sarcomas (ESS), the upregulation of miR-373-3p, miR-372-3p, and let-7b-5p, and the down-expression of let-7f-5p, miR-23-3p, and let-7b-5p were associated with lower CSS. Only miR-138-5p upregulation was associated with higher survival rates. miR-335-5p, miR-301a-3p, and miR-210-3p were more highly expressed in patients with tumor metastasis and relapse. miR-138-5p, miR-146b-5p, and miR-218-5p expression were associated with higher disease-free survival (DFS) in treated patients. These miRNAs represent potential prediction markers for prognosis and treatment response in these tumors.http://www.mdpi.com/2072-6694/10/9/315uterine sarcomascarcinosarcomamiRNAoncomirsmiRNA expression
spellingShingle Laura Gonzalez dos Anjos
Bruna Cristine de Almeida
Thais Gomes de Almeida
André Mourão Lavorato Rocha
Giovana De Nardo Maffazioli
Fernando Augusto Soares
Isabela Werneck da Cunha
Edmund Chada Baracat
Katia Candido Carvalho
Could miRNA Signatures be Useful for Predicting Uterine Sarcoma and Carcinosarcoma Prognosis and Treatment?
Cancers
uterine sarcomas
carcinosarcoma
miRNA
oncomirs
miRNA expression
title Could miRNA Signatures be Useful for Predicting Uterine Sarcoma and Carcinosarcoma Prognosis and Treatment?
title_full Could miRNA Signatures be Useful for Predicting Uterine Sarcoma and Carcinosarcoma Prognosis and Treatment?
title_fullStr Could miRNA Signatures be Useful for Predicting Uterine Sarcoma and Carcinosarcoma Prognosis and Treatment?
title_full_unstemmed Could miRNA Signatures be Useful for Predicting Uterine Sarcoma and Carcinosarcoma Prognosis and Treatment?
title_short Could miRNA Signatures be Useful for Predicting Uterine Sarcoma and Carcinosarcoma Prognosis and Treatment?
title_sort could mirna signatures be useful for predicting uterine sarcoma and carcinosarcoma prognosis and treatment
topic uterine sarcomas
carcinosarcoma
miRNA
oncomirs
miRNA expression
url http://www.mdpi.com/2072-6694/10/9/315
work_keys_str_mv AT lauragonzalezdosanjos couldmirnasignaturesbeusefulforpredictinguterinesarcomaandcarcinosarcomaprognosisandtreatment
AT brunacristinedealmeida couldmirnasignaturesbeusefulforpredictinguterinesarcomaandcarcinosarcomaprognosisandtreatment
AT thaisgomesdealmeida couldmirnasignaturesbeusefulforpredictinguterinesarcomaandcarcinosarcomaprognosisandtreatment
AT andremouraolavoratorocha couldmirnasignaturesbeusefulforpredictinguterinesarcomaandcarcinosarcomaprognosisandtreatment
AT giovanadenardomaffazioli couldmirnasignaturesbeusefulforpredictinguterinesarcomaandcarcinosarcomaprognosisandtreatment
AT fernandoaugustosoares couldmirnasignaturesbeusefulforpredictinguterinesarcomaandcarcinosarcomaprognosisandtreatment
AT isabelawerneckdacunha couldmirnasignaturesbeusefulforpredictinguterinesarcomaandcarcinosarcomaprognosisandtreatment
AT edmundchadabaracat couldmirnasignaturesbeusefulforpredictinguterinesarcomaandcarcinosarcomaprognosisandtreatment
AT katiacandidocarvalho couldmirnasignaturesbeusefulforpredictinguterinesarcomaandcarcinosarcomaprognosisandtreatment